Variability in performance of genetic-enhanced DXA-BMD prediction models across diverse ethnic and geographic populations: A risk prediction study

Osteoporosis is a major global health issue, weakening bones and increasing fracture risk. Dual-energy X-ray absorptiometry (DXA) is the standard for measuring bone mineral density (BMD) and diagnosing osteoporosis, but its costliness and complexity impede widespread screening adoption. Predictive m...

Full description

Saved in:
Bibliographic Details
Published inPLoS medicine Vol. 21; no. 8; p. e1004451
Main Authors Liu, Yong, Meng, Xiang-He, Wu, Chong, Su, Kuan-Jui, Liu, Anqi, Tian, Qing, Zhao, Lan-Juan, Qiu, Chuan, Luo, Zhe, Gonzalez-Ramirez, Martha I, Shen, Hui, Xiao, Hong-Mei, Deng, Hong-Wen
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 30.08.2024
Public Library of Science (PLoS)
Subjects
Absorptiometry, Photon
Adult
Aged
Biological models
Biology and Life Sciences
Bone densitometry
Bone Density - genetics
Bones
Density
Ethnicity - genetics
Female
Femur Neck - diagnostic imaging
Genes
Genomics
Health aspects
Humans
Lumbar Vertebrae - diagnostic imaging
Male
Medical research
Medicine and Health Sciences
Medicine, Experimental
Middle Aged
Osteoporosis
Osteoporosis - diagnosis
Osteoporosis - genetics
Osteoporotic Fractures - genetics
Physical Sciences
Polymorphism, Single Nucleotide
Research and Analysis Methods
Risk Assessment - methods
Risk Factors
Single nucleotide polymorphisms
Social aspects
United Kingdom
White People - genetics
World health
United Kingdom
China
Online AccessGet full text
ISSN1549-1676
1549-1277
1549-1676
DOI10.1371/journal.pmed.1004451

Cover

Abstract Osteoporosis is a major global health issue, weakening bones and increasing fracture risk. Dual-energy X-ray absorptiometry (DXA) is the standard for measuring bone mineral density (BMD) and diagnosing osteoporosis, but its costliness and complexity impede widespread screening adoption. Predictive modeling using genetic and clinical data offers a cost-effective alternative for assessing osteoporosis and fracture risk. This study aims to develop BMD prediction models using data from the UK Biobank (UKBB) and test their performance across different ethnic and geographical populations. We developed BMD prediction models for the femoral neck (FNK) and lumbar spine (SPN) using both genetic variants and clinical factors (such as sex, age, height, and weight), within 17,964 British white individuals from UKBB. Models based on regression with least absolute shrinkage and selection operator (LASSO), selected based on the coefficient of determination (R2) from a model selection subset of 5,973 individuals from British white population. These models were tested on 5 UKBB test sets and 12 independent cohorts of diverse ancestries, totaling over 15,000 individuals. Furthermore, we assessed the correlation of predicted BMDs with fragility fractures risk in 10 years in a case-control set of 287,183 European white participants without DXA-BMDs in the UKBB. With single-nucleotide polymorphism (SNP) inclusion thresholds at 5×10-6 and 5×10-7, the prediction models for FNK-BMD and SPN-BMD achieved the highest R2 of 27.70% with a 95% confidence interval (CI) of [27.56%, 27.84%] and 48.28% (95% CI [48.23%, 48.34%]), respectively. Adding genetic factors improved predictions slightly, explaining an additional 2.3% variation for FNK-BMD and 3% for SPN-BMD over clinical factors alone. Survival analysis revealed that the predicted FNK-BMD and SPN-BMD were significantly associated with fragility fracture risk in the European white population (P < 0.001). The hazard ratios (HRs) of the predicted FNK-BMD and SPN-BMD were 0.83 (95% CI [0.79, 0.88], corresponding to a 1.44% difference in 10-year absolute risk) and 0.72 (95% CI [0.68, 0.76], corresponding to a 1.64% difference in 10-year absolute risk), respectively, indicating that for every increase of one standard deviation in BMD, the fracture risk will decrease by 17% and 28%, respectively. However, the model's performance declined in other ethnic groups and independent cohorts. The limitations of this study include differences in clinical factors distribution and the use of only SNPs as genetic factors. In this study, we observed that combining genetic and clinical factors improves BMD prediction compared to clinical factors alone. Adjusting inclusion thresholds for genetic variants (e.g., 5×10-6 or 5×10-7) rather than solely considering genome-wide association study (GWAS)-significant variants can enhance the model's explanatory power. The study highlights the need for training models on diverse populations to improve predictive performance across various ethnic and geographical groups.
AbstractList Background Osteoporosis is a major global health issue, weakening bones and increasing fracture risk. Dual-energy X-ray absorptiometry (DXA) is the standard for measuring bone mineral density (BMD) and diagnosing osteoporosis, but its costliness and complexity impede widespread screening adoption. Predictive modeling using genetic and clinical data offers a cost-effective alternative for assessing osteoporosis and fracture risk. This study aims to develop BMD prediction models using data from the UK Biobank (UKBB) and test their performance across different ethnic and geographical populations. Methods and findings We developed BMD prediction models for the femoral neck (FNK) and lumbar spine (SPN) using both genetic variants and clinical factors (such as sex, age, height, and weight), within 17,964 British white individuals from UKBB. Models based on regression with least absolute shrinkage and selection operator (LASSO), selected based on the coefficient of determination (R.sup.2) from a model selection subset of 5,973 individuals from British white population. These models were tested on 5 UKBB test sets and 12 independent cohorts of diverse ancestries, totaling over 15,000 individuals. Furthermore, we assessed the correlation of predicted BMDs with fragility fractures risk in 10 years in a case-control set of 287,183 European white participants without DXA-BMDs in the UKBB. With single-nucleotide polymorphism (SNP) inclusion thresholds at 5x10.sup.-6 and 5x10.sup.-7, the prediction models for FNK-BMD and SPN-BMD achieved the highest R.sup.2 of 27.70% with a 95% confidence interval (CI) of [27.56%, 27.84%] and 48.28% (95% CI [48.23%, 48.34%]), respectively. Adding genetic factors improved predictions slightly, explaining an additional 2.3% variation for FNK-BMD and 3% for SPN-BMD over clinical factors alone. Survival analysis revealed that the predicted FNK-BMD and SPN-BMD were significantly associated with fragility fracture risk in the European white population (P < 0.001). The hazard ratios (HRs) of the predicted FNK-BMD and SPN-BMD were 0.83 (95% CI [0.79, 0.88], corresponding to a 1.44% difference in 10-year absolute risk) and 0.72 (95% CI [0.68, 0.76], corresponding to a 1.64% difference in 10-year absolute risk), respectively, indicating that for every increase of one standard deviation in BMD, the fracture risk will decrease by 17% and 28%, respectively. However, the model's performance declined in other ethnic groups and independent cohorts. The limitations of this study include differences in clinical factors distribution and the use of only SNPs as genetic factors. Conclusions In this study, we observed that combining genetic and clinical factors improves BMD prediction compared to clinical factors alone. Adjusting inclusion thresholds for genetic variants (e.g., 5x10.sup.-6 or 5x10.sup.-7) rather than solely considering genome-wide association study (GWAS)-significant variants can enhance the model's explanatory power. The study highlights the need for training models on diverse populations to improve predictive performance across various ethnic and geographical groups.
Osteoporosis is a major global health issue, weakening bones and increasing fracture risk. Dual-energy X-ray absorptiometry (DXA) is the standard for measuring bone mineral density (BMD) and diagnosing osteoporosis, but its costliness and complexity impede widespread screening adoption. Predictive modeling using genetic and clinical data offers a cost-effective alternative for assessing osteoporosis and fracture risk. This study aims to develop BMD prediction models using data from the UK Biobank (UKBB) and test their performance across different ethnic and geographical populations. We developed BMD prediction models for the femoral neck (FNK) and lumbar spine (SPN) using both genetic variants and clinical factors (such as sex, age, height, and weight), within 17,964 British white individuals from UKBB. Models based on regression with least absolute shrinkage and selection operator (LASSO), selected based on the coefficient of determination (R2) from a model selection subset of 5,973 individuals from British white population. These models were tested on 5 UKBB test sets and 12 independent cohorts of diverse ancestries, totaling over 15,000 individuals. Furthermore, we assessed the correlation of predicted BMDs with fragility fractures risk in 10 years in a case-control set of 287,183 European white participants without DXA-BMDs in the UKBB. With single-nucleotide polymorphism (SNP) inclusion thresholds at 5×10-6 and 5×10-7, the prediction models for FNK-BMD and SPN-BMD achieved the highest R2 of 27.70% with a 95% confidence interval (CI) of [27.56%, 27.84%] and 48.28% (95% CI [48.23%, 48.34%]), respectively. Adding genetic factors improved predictions slightly, explaining an additional 2.3% variation for FNK-BMD and 3% for SPN-BMD over clinical factors alone. Survival analysis revealed that the predicted FNK-BMD and SPN-BMD were significantly associated with fragility fracture risk in the European white population (P < 0.001). The hazard ratios (HRs) of the predicted FNK-BMD and SPN-BMD were 0.83 (95% CI [0.79, 0.88], corresponding to a 1.44% difference in 10-year absolute risk) and 0.72 (95% CI [0.68, 0.76], corresponding to a 1.64% difference in 10-year absolute risk), respectively, indicating that for every increase of one standard deviation in BMD, the fracture risk will decrease by 17% and 28%, respectively. However, the model's performance declined in other ethnic groups and independent cohorts. The limitations of this study include differences in clinical factors distribution and the use of only SNPs as genetic factors. In this study, we observed that combining genetic and clinical factors improves BMD prediction compared to clinical factors alone. Adjusting inclusion thresholds for genetic variants (e.g., 5×10-6 or 5×10-7) rather than solely considering genome-wide association study (GWAS)-significant variants can enhance the model's explanatory power. The study highlights the need for training models on diverse populations to improve predictive performance across various ethnic and geographical groups.
Yong Liu and co-workers compare
Osteoporosis is a major global health issue, weakening bones and increasing fracture risk. Dual-energy X-ray absorptiometry (DXA) is the standard for measuring bone mineral density (BMD) and diagnosing osteoporosis, but its costliness and complexity impede widespread screening adoption. Predictive modeling using genetic and clinical data offers a cost-effective alternative for assessing osteoporosis and fracture risk. This study aims to develop BMD prediction models using data from the UK Biobank (UKBB) and test their performance across different ethnic and geographical populations. We developed BMD prediction models for the femoral neck (FNK) and lumbar spine (SPN) using both genetic variants and clinical factors (such as sex, age, height, and weight), within 17,964 British white individuals from UKBB. Models based on regression with least absolute shrinkage and selection operator (LASSO), selected based on the coefficient of determination (R.sup.2) from a model selection subset of 5,973 individuals from British white population. These models were tested on 5 UKBB test sets and 12 independent cohorts of diverse ancestries, totaling over 15,000 individuals. Furthermore, we assessed the correlation of predicted BMDs with fragility fractures risk in 10 years in a case-control set of 287,183 European white participants without DXA-BMDs in the UKBB. In this study, we observed that combining genetic and clinical factors improves BMD prediction compared to clinical factors alone. Adjusting inclusion thresholds for genetic variants (e.g., 5x10.sup.-6 or 5x10.sup.-7) rather than solely considering genome-wide association study (GWAS)-significant variants can enhance the model's explanatory power. The study highlights the need for training models on diverse populations to improve predictive performance across various ethnic and geographical groups.
Osteoporosis is a major global health issue, weakening bones and increasing fracture risk. Dual-energy X-ray absorptiometry (DXA) is the standard for measuring bone mineral density (BMD) and diagnosing osteoporosis, but its costliness and complexity impede widespread screening adoption. Predictive modeling using genetic and clinical data offers a cost-effective alternative for assessing osteoporosis and fracture risk. This study aims to develop BMD prediction models using data from the UK Biobank (UKBB) and test their performance across different ethnic and geographical populations.BACKGROUNDOsteoporosis is a major global health issue, weakening bones and increasing fracture risk. Dual-energy X-ray absorptiometry (DXA) is the standard for measuring bone mineral density (BMD) and diagnosing osteoporosis, but its costliness and complexity impede widespread screening adoption. Predictive modeling using genetic and clinical data offers a cost-effective alternative for assessing osteoporosis and fracture risk. This study aims to develop BMD prediction models using data from the UK Biobank (UKBB) and test their performance across different ethnic and geographical populations.We developed BMD prediction models for the femoral neck (FNK) and lumbar spine (SPN) using both genetic variants and clinical factors (such as sex, age, height, and weight), within 17,964 British white individuals from UKBB. Models based on regression with least absolute shrinkage and selection operator (LASSO), selected based on the coefficient of determination (R2) from a model selection subset of 5,973 individuals from British white population. These models were tested on 5 UKBB test sets and 12 independent cohorts of diverse ancestries, totaling over 15,000 individuals. Furthermore, we assessed the correlation of predicted BMDs with fragility fractures risk in 10 years in a case-control set of 287,183 European white participants without DXA-BMDs in the UKBB. With single-nucleotide polymorphism (SNP) inclusion thresholds at 5×10-6 and 5×10-7, the prediction models for FNK-BMD and SPN-BMD achieved the highest R2 of 27.70% with a 95% confidence interval (CI) of [27.56%, 27.84%] and 48.28% (95% CI [48.23%, 48.34%]), respectively. Adding genetic factors improved predictions slightly, explaining an additional 2.3% variation for FNK-BMD and 3% for SPN-BMD over clinical factors alone. Survival analysis revealed that the predicted FNK-BMD and SPN-BMD were significantly associated with fragility fracture risk in the European white population (P < 0.001). The hazard ratios (HRs) of the predicted FNK-BMD and SPN-BMD were 0.83 (95% CI [0.79, 0.88], corresponding to a 1.44% difference in 10-year absolute risk) and 0.72 (95% CI [0.68, 0.76], corresponding to a 1.64% difference in 10-year absolute risk), respectively, indicating that for every increase of one standard deviation in BMD, the fracture risk will decrease by 17% and 28%, respectively. However, the model's performance declined in other ethnic groups and independent cohorts. The limitations of this study include differences in clinical factors distribution and the use of only SNPs as genetic factors.METHODS AND FINDINGSWe developed BMD prediction models for the femoral neck (FNK) and lumbar spine (SPN) using both genetic variants and clinical factors (such as sex, age, height, and weight), within 17,964 British white individuals from UKBB. Models based on regression with least absolute shrinkage and selection operator (LASSO), selected based on the coefficient of determination (R2) from a model selection subset of 5,973 individuals from British white population. These models were tested on 5 UKBB test sets and 12 independent cohorts of diverse ancestries, totaling over 15,000 individuals. Furthermore, we assessed the correlation of predicted BMDs with fragility fractures risk in 10 years in a case-control set of 287,183 European white participants without DXA-BMDs in the UKBB. With single-nucleotide polymorphism (SNP) inclusion thresholds at 5×10-6 and 5×10-7, the prediction models for FNK-BMD and SPN-BMD achieved the highest R2 of 27.70% with a 95% confidence interval (CI) of [27.56%, 27.84%] and 48.28% (95% CI [48.23%, 48.34%]), respectively. Adding genetic factors improved predictions slightly, explaining an additional 2.3% variation for FNK-BMD and 3% for SPN-BMD over clinical factors alone. Survival analysis revealed that the predicted FNK-BMD and SPN-BMD were significantly associated with fragility fracture risk in the European white population (P < 0.001). The hazard ratios (HRs) of the predicted FNK-BMD and SPN-BMD were 0.83 (95% CI [0.79, 0.88], corresponding to a 1.44% difference in 10-year absolute risk) and 0.72 (95% CI [0.68, 0.76], corresponding to a 1.64% difference in 10-year absolute risk), respectively, indicating that for every increase of one standard deviation in BMD, the fracture risk will decrease by 17% and 28%, respectively. However, the model's performance declined in other ethnic groups and independent cohorts. The limitations of this study include differences in clinical factors distribution and the use of only SNPs as genetic factors.In this study, we observed that combining genetic and clinical factors improves BMD prediction compared to clinical factors alone. Adjusting inclusion thresholds for genetic variants (e.g., 5×10-6 or 5×10-7) rather than solely considering genome-wide association study (GWAS)-significant variants can enhance the model's explanatory power. The study highlights the need for training models on diverse populations to improve predictive performance across various ethnic and geographical groups.CONCLUSIONSIn this study, we observed that combining genetic and clinical factors improves BMD prediction compared to clinical factors alone. Adjusting inclusion thresholds for genetic variants (e.g., 5×10-6 or 5×10-7) rather than solely considering genome-wide association study (GWAS)-significant variants can enhance the model's explanatory power. The study highlights the need for training models on diverse populations to improve predictive performance across various ethnic and geographical groups.
BackgroundOsteoporosis is a major global health issue, weakening bones and increasing fracture risk. Dual-energy X-ray absorptiometry (DXA) is the standard for measuring bone mineral density (BMD) and diagnosing osteoporosis, but its costliness and complexity impede widespread screening adoption. Predictive modeling using genetic and clinical data offers a cost-effective alternative for assessing osteoporosis and fracture risk. This study aims to develop BMD prediction models using data from the UK Biobank (UKBB) and test their performance across different ethnic and geographical populations.Methods and findingsWe developed BMD prediction models for the femoral neck (FNK) and lumbar spine (SPN) using both genetic variants and clinical factors (such as sex, age, height, and weight), within 17,964 British white individuals from UKBB. Models based on regression with least absolute shrinkage and selection operator (LASSO), selected based on the coefficient of determination (R2) from a model selection subset of 5,973 individuals from British white population. These models were tested on 5 UKBB test sets and 12 independent cohorts of diverse ancestries, totaling over 15,000 individuals. Furthermore, we assessed the correlation of predicted BMDs with fragility fractures risk in 10 years in a case-control set of 287,183 European white participants without DXA-BMDs in the UKBB. With single-nucleotide polymorphism (SNP) inclusion thresholds at 5×10-6 and 5×10-7, the prediction models for FNK-BMD and SPN-BMD achieved the highest R2 of 27.70% with a 95% confidence interval (CI) of [27.56%, 27.84%] and 48.28% (95% CI [48.23%, 48.34%]), respectively. Adding genetic factors improved predictions slightly, explaining an additional 2.3% variation for FNK-BMD and 3% for SPN-BMD over clinical factors alone. Survival analysis revealed that the predicted FNK-BMD and SPN-BMD were significantly associated with fragility fracture risk in the European white population (P < 0.001). The hazard ratios (HRs) of the predicted FNK-BMD and SPN-BMD were 0.83 (95% CI [0.79, 0.88], corresponding to a 1.44% difference in 10-year absolute risk) and 0.72 (95% CI [0.68, 0.76], corresponding to a 1.64% difference in 10-year absolute risk), respectively, indicating that for every increase of one standard deviation in BMD, the fracture risk will decrease by 17% and 28%, respectively. However, the model's performance declined in other ethnic groups and independent cohorts. The limitations of this study include differences in clinical factors distribution and the use of only SNPs as genetic factors.ConclusionsIn this study, we observed that combining genetic and clinical factors improves BMD prediction compared to clinical factors alone. Adjusting inclusion thresholds for genetic variants (e.g., 5×10-6 or 5×10-7) rather than solely considering genome-wide association study (GWAS)-significant variants can enhance the model's explanatory power. The study highlights the need for training models on diverse populations to improve predictive performance across various ethnic and geographical groups.
Audience Academic
Author Meng, Xiang-He
Deng, Hong-Wen
Luo, Zhe
Gonzalez-Ramirez, Martha I
Wu, Chong
Xiao, Hong-Mei
Qiu, Chuan
Liu, Anqi
Tian, Qing
Su, Kuan-Jui
Shen, Hui
Liu, Yong
Zhao, Lan-Juan
AuthorAffiliation 4 Tulane Center of Biomedical Informatics and Genomics, Deming Department of Medicine, School of Medicine, Tulane University, New Orleans, Louisiana, United States of America
1 Center for System Biology, Data Sciences, and Reproductive Health, School of Basic Medical Science, Central South University, Changsha, Hunan Province, China
2 Hunan Provincial Key Laboratory of Regional Hereditary Birth Defects Prevention and Control, Changsha Hospital for Maternal & Child Health Care Affiliated to Hunan Normal University, Changsha, Hunan Province, China
3 Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
5 Key Laboratory of Biological, Nanotechnology of National Health Commission, Xiangya Hospital, Central South University, Changsha, Hunan Province, China
AuthorAffiliation_xml – name: 4 Tulane Center of Biomedical Informatics and Genomics, Deming Department of Medicine, School of Medicine, Tulane University, New Orleans, Louisiana, United States of America
– name: 3 Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
– name: 2 Hunan Provincial Key Laboratory of Regional Hereditary Birth Defects Prevention and Control, Changsha Hospital for Maternal & Child Health Care Affiliated to Hunan Normal University, Changsha, Hunan Province, China
– name: 5 Key Laboratory of Biological, Nanotechnology of National Health Commission, Xiangya Hospital, Central South University, Changsha, Hunan Province, China
– name: 1 Center for System Biology, Data Sciences, and Reproductive Health, School of Basic Medical Science, Central South University, Changsha, Hunan Province, China
Author_xml – sequence: 1
  givenname: Yong
  orcidid: 0000-0001-9360-1304
  surname: Liu
  fullname: Liu, Yong
– sequence: 2
  givenname: Xiang-He
  orcidid: 0000-0001-8731-2899
  surname: Meng
  fullname: Meng, Xiang-He
– sequence: 3
  givenname: Chong
  surname: Wu
  fullname: Wu, Chong
– sequence: 4
  givenname: Kuan-Jui
  orcidid: 0000-0002-5163-9774
  surname: Su
  fullname: Su, Kuan-Jui
– sequence: 5
  givenname: Anqi
  surname: Liu
  fullname: Liu, Anqi
– sequence: 6
  givenname: Qing
  surname: Tian
  fullname: Tian, Qing
– sequence: 7
  givenname: Lan-Juan
  surname: Zhao
  fullname: Zhao, Lan-Juan
– sequence: 8
  givenname: Chuan
  surname: Qiu
  fullname: Qiu, Chuan
– sequence: 9
  givenname: Zhe
  orcidid: 0000-0001-6495-408X
  surname: Luo
  fullname: Luo, Zhe
– sequence: 10
  givenname: Martha I
  surname: Gonzalez-Ramirez
  fullname: Gonzalez-Ramirez, Martha I
– sequence: 11
  givenname: Hui
  surname: Shen
  fullname: Shen, Hui
– sequence: 12
  givenname: Hong-Mei
  orcidid: 0000-0002-8121-9498
  surname: Xiao
  fullname: Xiao, Hong-Mei
– sequence: 13
  givenname: Hong-Wen
  orcidid: 0000-0002-0387-8818
  surname: Deng
  fullname: Deng, Hong-Wen
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39213443$$D View this record in MEDLINE/PubMed
BookMark eNqVk9tu1DAQhiNURA_wBghZQkJwkcVOnFNv0NJyWKlQiUPFnTVxJrveJnawk4p9DZ4YZ3epdlGFQLlIPPn-P7Fn_uPgQBuNQfCY0QmLM_ZyaQaroZl0LVYTRinnCbsXHLGEFyFLs_Rg5_kwOHZuSWlU0II-CA7jImIx5_FR8PMKrIJSNapfEaVJh7Y2tgUtkZiazFFjr2SIejGWKnL-bRq-_nBOOouVkr0ymrSmwsYRkNY4Ryp1g9YhwX6hlSSgK29i5ha6hV92phsaGGXulEyJVe5618r1Q7V6GNyvoXH4aHs_Cb6-ffPl7H14cfludja9CGXG4j7ELMuTNJW1xFRiDEXNsygr0zKiSRllPKVpVKUxlhkUWELpK0VdVszvAkr0ipNgtvGtDCxFZ1ULdiUMKLEuGDsXYP3mGxQ5K4DnhT-1nPOC5ZACr5DnWZ5RyNPEe73aeHVD6fshUfcWmj3T_TdaLcTc3AjGOOU5Hx2ebx2s-T6g60WrnMSmAY1mcCKmRZHT2MMefbpB5-D_TenaeEs54mKa04x7Khmp8A5qbKj_vh-lWvnyHj-5g_dXha2Sdwpe7Ak80-OPfg6Dc2L2-dN_sB__nb282mef7bALhKZfONMM6wnbB5_sNui2M7-T4AG-AdZjbLG-RRgVY-DENnBiDJzYBs7LTv-QSdWvB9yfnmr-Lv4F87czjg
CitedBy_id crossref_primary_10_1097_JS9_0000000000002187
Cites_doi 10.1038/s41574-019-0282-7
10.1001/jama.285.6.785
10.1186/s13073-021-00838-6
10.1093/hmg/ddab305
10.1007/s001980170112
10.7326/AITC201708010
10.1038/s41586-018-0579-z
10.1038/s41588-019-0379-x
10.1007/978-0-387-32833-1_251
10.1186/s12916-022-02583-y
10.1093/bioinformatics/btq559
10.3233/JAD-220025
10.1002/jbmr.5650110414
10.1111/j.1467-9868.2011.00771.x
10.1073/pnas.2203033119
10.1002/jbmr.3381
10.1038/ng.3656
10.1002/jbmr.2709
10.1038/s41467-024-49296-9
10.1002/jbmr.1955
10.1016/1047-2797(91)90005-W
10.1371/journal.pmed.1001779
10.1093/eurheartj/ehac460
10.1038/nature11632
10.1186/s40537-021-00444-8
10.1007/978-1-4614-8265-9_566
10.1371/journal.pgen.1008624
10.1161/CIRCGEN.120.002932
10.1136/bmj-2022-073149
10.1210/jc.2009-2406
10.3389/fendo.2018.00380
10.1016/S0140-6736(10)62349-5
10.1007/s11999-014-3820-6
10.1186/s13073-024-01337-0
10.1016/S0197-2456(97)00078-0
10.1038/nature14962
10.1093/bib/bbae240
10.1371/journal.pmed.1002279
10.1007/978-3-319-69287-6_25
10.1186/s13073-020-00742-5
10.1186/s40842-018-0062-7
10.1093/hmg/ddt575
10.1371/journal.pgen.1004423
10.1055/s-0036-1584359
10.1007/s00198-004-1780-5
10.1038/s41588-018-0144-6
10.1359/jbmr.070606
10.1093/bioinformatics/btx299
10.1097/BOR.0000000000000789
10.1007/s00198-004-1771-6
10.1007/s11657-017-0324-5
10.1038/s41586-023-06079-4
10.1016/S0140-6736(02)08761-5
10.1016/j.cct.2005.05.006
10.1007/s00198-007-0543-5
10.1093/gerona/56.6.B248
10.1002/jbmr.2998
10.1038/ng.3643
ContentType Journal Article
Copyright Copyright: © 2024 Liu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
COPYRIGHT 2024 Public Library of Science
2024 Liu et al 2024 Liu et al
Copyright_xml – notice: Copyright: © 2024 Liu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
– notice: COPYRIGHT 2024 Public Library of Science
– notice: 2024 Liu et al 2024 Liu et al
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISN
ISR
7X8
5PM
DOA
DOI 10.1371/journal.pmed.1004451
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Opposing Viewpoints
Gale In Context: Canada
Gale In Context: Science
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE





MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Open Access Full Text
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Ethnic and geographical variability in genetic-enhanced DXA-BMD prediction models
EISSN 1549-1676
ExternalDocumentID oai_doaj_org_article_819a489921844918a6a4de487870a865
PMC11404845
A807403058
39213443
10_1371_journal_pmed_1004451
Genre Journal Article
GeographicLocations United Kingdom
China
GeographicLocations_xml – name: United Kingdom
– name: China
GrantInformation_xml – fundername: NIGMS NIH HHS
  grantid: P20 GM109036
– fundername: NIA NIH HHS
  grantid: R01 AG061917
– fundername: NIA NIH HHS
  grantid: R01 AG068232
– fundername: NIA NIH HHS
  grantid: U19 AG055373
– fundername: ;
– fundername: ;
  grantid: #81471453
– fundername: ;
  grantid: 2017YFC1001103, 2016YFC1201805
GroupedDBID ---
123
29O
2WC
53G
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAUCC
AAWOE
AAWTL
AAYXX
ABDBF
ABUWG
ACGFO
ACIHN
ACPRK
ACUHS
ADBBV
AEAQA
AENEX
AFKRA
AFPKN
AFRAH
AFXKF
AHMBA
AKRSQ
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
B0M
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAP
EAS
EBD
EBS
EJD
EMK
EMOBN
ESX
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
IHW
INH
INR
IOF
IOV
IPO
ISN
ISR
ITC
KQ8
M1P
M48
MK0
O5R
O5S
OK1
OVT
P2P
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PV9
RNS
RPM
RZL
SV3
TR2
TUS
UKHRP
WOW
XSB
YZZ
~8M
ADRAZ
CGR
CUY
CVF
ECM
EIF
H13
IPNFZ
NPM
RIG
WOQ
PMFND
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c713t-e778566cfce6ce3a9f4727b6b205b2746062d63eb7a9ebab7469fbd1cedabece3
IEDL.DBID M48
ISSN 1549-1676
1549-1277
IngestDate Wed Aug 27 01:15:10 EDT 2025
Thu Aug 21 18:34:50 EDT 2025
Fri Sep 05 05:58:16 EDT 2025
Tue Jun 17 22:04:43 EDT 2025
Fri Jun 13 00:15:46 EDT 2025
Tue Jun 10 21:07:08 EDT 2025
Fri Jun 27 05:27:47 EDT 2025
Fri Jun 27 05:54:52 EDT 2025
Fri Jun 27 05:55:14 EDT 2025
Thu May 22 21:24:11 EDT 2025
Mon Apr 07 02:11:19 EDT 2025
Thu Apr 24 22:56:08 EDT 2025
Sat Jul 26 02:21:44 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
License Copyright: © 2024 Liu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c713t-e778566cfce6ce3a9f4727b6b205b2746062d63eb7a9ebab7469fbd1cedabece3
Notes new_version
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
The authors have declared that no competing interests exist.
ORCID 0000-0002-5163-9774
0000-0001-6495-408X
0000-0001-8731-2899
0000-0001-9360-1304
0000-0002-8121-9498
0000-0002-0387-8818
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pmed.1004451
PMID 39213443
PQID 3099803048
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_819a489921844918a6a4de487870a865
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11404845
proquest_miscellaneous_3099803048
gale_infotracmisc_A807403058
gale_infotracgeneralonefile_A807403058
gale_infotracacademiconefile_A807403058
gale_incontextgauss_ISR_A807403058
gale_incontextgauss_ISN_A807403058
gale_incontextgauss_IOV_A807403058
gale_healthsolutions_A807403058
pubmed_primary_39213443
crossref_primary_10_1371_journal_pmed_1004451
crossref_citationtrail_10_1371_journal_pmed_1004451
PublicationCentury 2000
PublicationDate 20240830
PublicationDateYYYYMMDD 2024-08-30
PublicationDate_xml – month: 8
  year: 2024
  text: 20240830
  day: 30
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco, CA USA
PublicationTitle PLoS medicine
PublicationTitleAlternate PLoS Med
PublicationYear 2024
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References EL Duncan (pmed.1004451.ref013) 2010; 95
A Sud (pmed.1004451.ref020) 2023; 380
F Buttgereit (pmed.1004451.ref049) 2024
E Kinning (pmed.1004451.ref061) 2016; 5
P Aghajanian (pmed.1004451.ref062) 2015; 30
Nih Consensus Development Panel on Osteoporosis Prevention D, Therapy (pmed.1004451.ref005) 2001; 285
Q Gu (pmed.1004451.ref004) 2014; 472
JP Kemp (pmed.1004451.ref054) 2014; 10
AR Martin (pmed.1004451.ref058) 2019; 51
A Manichaikul (pmed.1004451.ref030) 2010; 26
JA Kanis (pmed.1004451.ref002) 2001; 12
A King (pmed.1004451.ref065) 2022; 20
P Choksi (pmed.1004451.ref007) 2018; 4
Y-H Hsu (pmed.1004451.ref019) 2020
T Lu (pmed.1004451.ref017) 2021; 13
R. Tibshirani (pmed.1004451.ref041) 2011; 73
B Ding (pmed.1004451.ref043) 2018
TD Rachner (pmed.1004451.ref003) 2011; 377
JA Kanis (pmed.1004451.ref001) 2002; 359
DA Turner (pmed.1004451.ref009) 2018; 33
JA Kanis (pmed.1004451.ref022) 2005; 16
PR Loh (pmed.1004451.ref037) 2018; 50
K Clark (pmed.1004451.ref039) 2022; 89
D Gola (pmed.1004451.ref059) 2020; 13
L Alzubaidi (pmed.1004451.ref042) 2021; 8
L Zhang (pmed.1004451.ref029) 2014; 23
NK Arden (pmed.1004451.ref012) 1996; 11
KD Wysham (pmed.1004451.ref048) 2021; 33
S Das (pmed.1004451.ref034) 2016; 48
A Costantini (pmed.1004451.ref060) 2018; 9
M Piroska (pmed.1004451.ref055) 2021; 57
TL Yang (pmed.1004451.ref011) 2020; 16
SH Lee (pmed.1004451.ref015) 2013; 28
SM Urbut (pmed.1004451.ref064) 2024; 15
R Mandla (pmed.1004451.ref066) 2024; 16
C Sudlow (pmed.1004451.ref028) 2015; 12
A Vuillemin (pmed.1004451.ref057) 2001; 56
SW Choi (pmed.1004451.ref038) 2019; 8
T Krainc (pmed.1004451.ref052) 2022; 119
LP Fried (pmed.1004451.ref027) 1991; 1
JL Kelsey (pmed.1004451.ref010) 1989; 104 Suppl
J Greenbaum (pmed.1004451.ref024) 2022; 31
C Bycroft (pmed.1004451.ref023) 2018; 562
Y Ding (pmed.1004451.ref035) 2023; 618
I Mathieson (pmed.1004451.ref053) 2020; 16
CM Lewis (pmed.1004451.ref014) 2020; 12
(pmed.1004451.ref044) 2008
HL SEAL (pmed.1004451.ref040) 1967; 54
JA Kanis (pmed.1004451.ref050) 2008; 19
C Genomes Project (pmed.1004451.ref033) 2012; 491
Design of the Women’s Health Initiative clinical trial and observational study (pmed.1004451.ref026) 1998; 19
H Yu (pmed.1004451.ref047) 2018
J Schwarzerova (pmed.1004451.ref021) 2024; 25
E Orwoll (pmed.1004451.ref025) 2005; 26
S Gonnelli (pmed.1004451.ref018) 2005; 16
NA Marston (pmed.1004451.ref063) 2023; 44
S McCarthy (pmed.1004451.ref031) 2016; 48
H Du (pmed.1004451.ref051) 2017; 14
TP Ho-Le (pmed.1004451.ref016) 2017; 32
D Kingma (pmed.1004451.ref046) 2014
FC Dannhauser (pmed.1004451.ref067) 2024
UK Consortium (pmed.1004451.ref032) 2015; 526
T Videman (pmed.1004451.ref056) 2007; 22
G Abraham (pmed.1004451.ref036) 2017; 33
S. Ruder (pmed.1004451.ref045) 2016
J Compston (pmed.1004451.ref008) 2017; 12
KE Ensrud (pmed.1004451.ref006) 2017; 167
References_xml – volume: 16
  start-page: 91
  issue: 2
  year: 2020
  ident: pmed.1004451.ref011
  article-title: A road map for understanding molecular and genetic determinants of osteoporosis.
  publication-title: Nat Rev Endocrinol.
  doi: 10.1038/s41574-019-0282-7
– volume: 285
  start-page: 785
  issue: 6
  year: 2001
  ident: pmed.1004451.ref005
  article-title: Osteoporosis prevention, diagnosis, and therapy.
  publication-title: JAMA
  doi: 10.1001/jama.285.6.785
– volume: 13
  start-page: 16
  issue: 1
  year: 2021
  ident: pmed.1004451.ref017
  article-title: Improved prediction of fracture risk leveraging a genome-wide polygenic risk score
  publication-title: Genome Med
  doi: 10.1186/s13073-021-00838-6
– volume: 31
  start-page: 1067
  issue: 7
  year: 2022
  ident: pmed.1004451.ref024
  article-title: A multiethnic whole genome sequencing study to identify novel loci for bone mineral density
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddab305
– volume: 12
  start-page: 417
  issue: 5
  year: 2001
  ident: pmed.1004451.ref002
  article-title: The burden of osteoporotic fractures: a method for setting intervention thresholds.
  publication-title: Osteoporos Int
  doi: 10.1007/s001980170112
– volume: 167
  start-page: ITC17
  issue: 3
  year: 2017
  ident: pmed.1004451.ref006
  article-title: Osteoporosis.
  publication-title: Ann Intern Med
  doi: 10.7326/AITC201708010
– volume: 562
  start-page: 203
  issue: 7726
  year: 2018
  ident: pmed.1004451.ref023
  article-title: The UK Biobank resource with deep phenotyping and genomic data
  publication-title: Nature
  doi: 10.1038/s41586-018-0579-z
– volume: 51
  start-page: 584
  issue: 4
  year: 2019
  ident: pmed.1004451.ref058
  article-title: Clinical use of current polygenic risk scores may exacerbate health disparities
  publication-title: Nat Genet
  doi: 10.1038/s41588-019-0379-x
– start-page: 337
  volume-title: The Concise Encyclopedia of Statistics.
  year: 2008
  ident: pmed.1004451.ref044
  doi: 10.1007/978-0-387-32833-1_251
– volume: 20
  start-page: 385
  issue: 1
  year: 2022
  ident: pmed.1004451.ref065
  article-title: Polygenic risk score improves the accuracy of a clinical risk score for coronary artery disease
  publication-title: BMC Med
  doi: 10.1186/s12916-022-02583-y
– volume: 26
  start-page: 2867
  issue: 22
  year: 2010
  ident: pmed.1004451.ref030
  article-title: Robust relationship inference in genome-wide association studies
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btq559
– year: 2024
  ident: pmed.1004451.ref049
  article-title: Osteoporosis and fracture risk are multifactorial in patients with inflammatory rheumatic diseases.
  publication-title: Nat Rev Rheumatol.
– volume: 89
  start-page: 1
  issue: 1
  year: 2022
  ident: pmed.1004451.ref039
  article-title: Polygenic Risk Scores in Alzheimer’s Disease Genetics: Methodology, Applications, Inclusion, and Diversity
  publication-title: J Alzheimers Dis
  doi: 10.3233/JAD-220025
– start-page: abs/1609.04747
  volume-title: An overview of gradient descent optimization algorithms
  year: 2016
  ident: pmed.1004451.ref045
– volume: 54
  start-page: 1
  issue: 1–2
  year: 1967
  ident: pmed.1004451.ref040
  article-title: Studies in the History of Probability and Statistics. XV The historical development of the Gauss linear model
  publication-title: Biometrika
– volume: 11
  start-page: 530
  issue: 4
  year: 1996
  ident: pmed.1004451.ref012
  article-title: The heritability of bone mineral density, ultrasound of the calcaneus and hip axis length: a study of postmenopausal twins
  publication-title: J Bone Miner Res
  doi: 10.1002/jbmr.5650110414
– volume: 73
  start-page: 273
  issue: 3
  year: 2011
  ident: pmed.1004451.ref041
  article-title: Regression Shrinkage and Selection via The Lasso: A Retrospective.
  publication-title: J R Stat Soc Series B Stat Methodol
  doi: 10.1111/j.1467-9868.2011.00771.x
– volume: 119
  start-page: e2203033119
  issue: 12
  year: 2022
  ident: pmed.1004451.ref052
  article-title: Genetic ancestry in precision medicine is reshaping the race debate
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.2203033119
– volume: 33
  start-page: 845
  issue: 5
  year: 2018
  ident: pmed.1004451.ref009
  article-title: The Cost-Effectiveness of Screening in the Community to Reduce Osteoporotic Fractures in Older Women in the UK: Economic Evaluation of the SCOOP Study
  publication-title: J Bone Miner Res
  doi: 10.1002/jbmr.3381
– volume: 48
  start-page: 1284
  issue: 10
  year: 2016
  ident: pmed.1004451.ref034
  article-title: Next-generation genotype imputation service and methods
  publication-title: Nat Genet
  doi: 10.1038/ng.3656
– volume: 30
  start-page: 1945
  issue: 11
  year: 2015
  ident: pmed.1004451.ref062
  article-title: The Roles and Mechanisms of Actions of Vitamin C in Bone: New Developments
  publication-title: J Bone Miner Res
  doi: 10.1002/jbmr.2709
– volume: 15
  start-page: 4884
  issue: 1
  year: 2024
  ident: pmed.1004451.ref064
  article-title: MSGene: a multistate model using genetic risk and the electronic health record applied to lifetime risk of coronary artery disease
  publication-title: Nat Commun
  doi: 10.1038/s41467-024-49296-9
– year: 2024
  ident: pmed.1004451.ref067
  article-title: The acceptability and clinical impact of using polygenic scores for risk-estimation of common cancers in primary care: a systematic review.
  publication-title: J Community Genet.
– volume: 28
  start-page: 2156
  issue: 10
  year: 2013
  ident: pmed.1004451.ref015
  article-title: Multiple gene polymorphisms can improve prediction of nonvertebral fracture in postmenopausal women
  publication-title: J Bone Miner Res
  doi: 10.1002/jbmr.1955
– volume: 1
  start-page: 263
  issue: 3
  year: 1991
  ident: pmed.1004451.ref027
  article-title: The Cardiovascular Health Study: design and rationale.
  publication-title: Ann Epidemiol.
  doi: 10.1016/1047-2797(91)90005-W
– year: 2018
  ident: pmed.1004451.ref043
– volume: 12
  start-page: e1001779
  issue: 3
  year: 2015
  ident: pmed.1004451.ref028
  article-title: UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age.
  publication-title: PLoS Med
  doi: 10.1371/journal.pmed.1001779
– volume: 44
  start-page: 221
  issue: 3
  year: 2023
  ident: pmed.1004451.ref063
  article-title: A polygenic risk score predicts atrial fibrillation in cardiovascular disease
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehac460
– volume: 8
  issue: 7
  year: 2019
  ident: pmed.1004451.ref038
  article-title: PRSice-2: Polygenic Risk Score software for biobank-scale data.
  publication-title: Gigascience
– volume: 491
  start-page: 56
  issue: 7422
  year: 2012
  ident: pmed.1004451.ref033
  article-title: An integrated map of genetic variation from 1,092 human genomes
  publication-title: Nature
  doi: 10.1038/nature11632
– volume: 8
  start-page: 53
  issue: 1
  year: 2021
  ident: pmed.1004451.ref042
  article-title: Review of deep learning: concepts, CNN architectures, challenges, applications, future directions.
  publication-title: J Big Data.
  doi: 10.1186/s40537-021-00444-8
– start-page: 335
  volume-title: Encyclopedia of Database Systems
  year: 2018
  ident: pmed.1004451.ref047
  doi: 10.1007/978-1-4614-8265-9_566
– volume: 16
  start-page: e1008624
  issue: 3
  year: 2020
  ident: pmed.1004451.ref053
  article-title: What is ancestry?
  publication-title: PLoS Genet.
  doi: 10.1371/journal.pgen.1008624
– volume: 13
  start-page: e002932
  issue: 6
  year: 2020
  ident: pmed.1004451.ref059
  article-title: Population Bias in Polygenic Risk Prediction Models for Coronary Artery Disease.
  publication-title: Circ Genom Precis Med
  doi: 10.1161/CIRCGEN.120.002932
– volume: 380
  start-page: e073149
  year: 2023
  ident: pmed.1004451.ref020
  article-title: Realistic expectations are key to realising the benefits of polygenic scores
  publication-title: BMJ
  doi: 10.1136/bmj-2022-073149
– volume: 57
  issue: 3
  year: 2021
  ident: pmed.1004451.ref055
  article-title: Strong Genetic Effects on Bone Mineral Density in Multiple Locations with Two Different Techniques: Results from a Cross-Sectional Twin Study.
  publication-title: Medicina (Kaunas).
– volume: 95
  start-page: 2576
  issue: 6
  year: 2010
  ident: pmed.1004451.ref013
  article-title: Clinical review 2: Genetic determinants of bone density and fracture risk—state of the art and future directions
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2009-2406
– volume: 9
  start-page: 380
  year: 2018
  ident: pmed.1004451.ref060
  article-title: Rare Copy Number Variants in Array-Based Comparative Genomic Hybridization in Early-Onset Skeletal Fragility.
  publication-title: Front Endocrinol (Lausanne).
  doi: 10.3389/fendo.2018.00380
– volume: 377
  start-page: 1276
  issue: 9773
  year: 2011
  ident: pmed.1004451.ref003
  article-title: Osteoporosis: now and the future
  publication-title: Lancet
  doi: 10.1016/S0140-6736(10)62349-5
– volume: 472
  start-page: 3536
  issue: 11
  year: 2014
  ident: pmed.1004451.ref004
  article-title: Surgery for hip fracture yields societal benefits that exceed the direct medical costs
  publication-title: Clin Orthop Relat Res
  doi: 10.1007/s11999-014-3820-6
– volume: 16
  start-page: 63
  issue: 1
  year: 2024
  ident: pmed.1004451.ref066
  article-title: Polygenic scores for longitudinal prediction of incident type 2 diabetes in an ancestrally and medically diverse primary care physician network: a patient cohort study
  publication-title: Genome Med
  doi: 10.1186/s13073-024-01337-0
– volume: 19
  start-page: 61
  issue: 1
  year: 1998
  ident: pmed.1004451.ref026
  article-title: The Women’s Health Initiative Study Group.
  publication-title: Control Clin Trials
  doi: 10.1016/S0197-2456(97)00078-0
– volume: 526
  start-page: 82
  issue: 7571
  year: 2015
  ident: pmed.1004451.ref032
  article-title: The UK10K project identifies rare variants in health and disease
  publication-title: Nature
  doi: 10.1038/nature14962
– volume: 25
  issue: 3
  year: 2024
  ident: pmed.1004451.ref021
  article-title: A perspective on genetic and polygenic risk scores-advances and limitations and overview of associated tools
  publication-title: Brief Bioinform
  doi: 10.1093/bib/bbae240
– volume: 14
  start-page: e1002279
  issue: 4
  year: 2017
  ident: pmed.1004451.ref051
  article-title: Fresh fruit consumption in relation to incident diabetes and diabetic vascular complications: A 7-y prospective study of 0.5 million Chinese adults.
  publication-title: PLoS Med.
  doi: 10.1371/journal.pmed.1002279
– start-page: 485
  volume-title: Osteoporosis: Pathophysiology and Clinical Management.
  year: 2020
  ident: pmed.1004451.ref019
  doi: 10.1007/978-3-319-69287-6_25
– volume: 12
  start-page: 44
  issue: 1
  year: 2020
  ident: pmed.1004451.ref014
  article-title: Polygenic risk scores: from research tools to clinical instruments
  publication-title: Genome Med
  doi: 10.1186/s13073-020-00742-5
– volume: 4
  start-page: 12
  year: 2018
  ident: pmed.1004451.ref007
  article-title: The challenges of diagnosing osteoporosis and the limitations of currently available tools
  publication-title: Clin Diabetes Endocrinol
  doi: 10.1186/s40842-018-0062-7
– volume: 23
  start-page: 1923
  issue: 7
  year: 2014
  ident: pmed.1004451.ref029
  article-title: Multistage genome-wide association meta-analyses identified two new loci for bone mineral density
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddt575
– volume: 10
  start-page: e1004423
  issue: 6
  year: 2014
  ident: pmed.1004451.ref054
  article-title: Phenotypic dissection of bone mineral density reveals skeletal site specificity and facilitates the identification of novel loci in the genetic regulation of bone mass attainment
  publication-title: PLoS Genet
  doi: 10.1371/journal.pgen.1004423
– volume: 5
  start-page: 167
  issue: 3
  year: 2016
  ident: pmed.1004451.ref061
  article-title: An Unbalanced Rearrangement of Chromosomes 4:20 is Associated with Childhood Osteoporosis and Reduced Caspase-3 Levels
  publication-title: J Pediatr Genet
  doi: 10.1055/s-0036-1584359
– volume: 16
  start-page: 581
  issue: 6
  year: 2005
  ident: pmed.1004451.ref022
  article-title: Assessment of fracture risk.
  publication-title: Osteoporos Int.
  doi: 10.1007/s00198-004-1780-5
– volume: 50
  start-page: 906
  issue: 7
  year: 2018
  ident: pmed.1004451.ref037
  article-title: Mixed-model association for biobank-scale datasets
  publication-title: Nat Genet
  doi: 10.1038/s41588-018-0144-6
– volume: 22
  start-page: 1455
  issue: 9
  year: 2007
  ident: pmed.1004451.ref056
  article-title: Heritability of BMD of femoral neck and lumbar spine: a multivariate twin study of Finnish men
  publication-title: J Bone Miner Res
  doi: 10.1359/jbmr.070606
– volume: 104 Suppl
  start-page: 14
  issue: Suppl
  year: 1989
  ident: pmed.1004451.ref010
  article-title: Risk factors for osteoporosis and associated fractures
  publication-title: Public Health Rep
– volume: 33
  start-page: 2776
  issue: 17
  year: 2017
  ident: pmed.1004451.ref036
  article-title: FlashPCA2: principal component analysis of Biobank-scale genotype datasets
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btx299
– year: 2014
  ident: pmed.1004451.ref046
  article-title: Adam: A Method for Stochastic Optimization
  publication-title: Computer Science
– volume: 33
  start-page: 270
  issue: 3
  year: 2021
  ident: pmed.1004451.ref048
  article-title: Osteoporosis and fractures in rheumatoid arthritis.
  publication-title: Curr Opin Rheumatol
  doi: 10.1097/BOR.0000000000000789
– volume: 16
  start-page: 963
  issue: 8
  year: 2005
  ident: pmed.1004451.ref018
  article-title: Quantitative ultrasound and dual-energy X-ray absorptiometry in the prediction of fragility fracture in men.
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-004-1771-6
– volume: 12
  start-page: 43
  issue: 1
  year: 2017
  ident: pmed.1004451.ref008
  article-title: UK clinical guideline for the prevention and treatment of osteoporosis.
  publication-title: Arch Osteoporos
  doi: 10.1007/s11657-017-0324-5
– volume: 618
  start-page: 774
  issue: 7966
  year: 2023
  ident: pmed.1004451.ref035
  article-title: Polygenic scoring accuracy varies across the genetic ancestry continuum
  publication-title: Nature
  doi: 10.1038/s41586-023-06079-4
– volume: 359
  start-page: 1929
  issue: 9321
  year: 2002
  ident: pmed.1004451.ref001
  article-title: Diagnosis of osteoporosis and assessment of fracture risk
  publication-title: Lancet
  doi: 10.1016/S0140-6736(02)08761-5
– volume: 26
  start-page: 569
  issue: 5
  year: 2005
  ident: pmed.1004451.ref025
  article-title: Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study—a large observational study of the determinants of fracture in older men.
  publication-title: Contemp Clin Trials
  doi: 10.1016/j.cct.2005.05.006
– volume: 19
  start-page: 385
  issue: 4
  year: 2008
  ident: pmed.1004451.ref050
  article-title: FRAX and the assessment of fracture probability in men and women from the UK.
  publication-title: Osteoporos Int.
  doi: 10.1007/s00198-007-0543-5
– volume: 56
  start-page: B248
  issue: 6
  year: 2001
  ident: pmed.1004451.ref057
  article-title: Differential influence of physical activity on lumbar spine and femoral neck bone mineral density in the elderly population
  publication-title: J Gerontol A Biol Sci Med Sci
  doi: 10.1093/gerona/56.6.B248
– volume: 32
  start-page: 285
  issue: 2
  year: 2017
  ident: pmed.1004451.ref016
  article-title: Prediction of Bone Mineral Density and Fragility Fracture by Genetic Profiling
  publication-title: J Bone Miner Res
  doi: 10.1002/jbmr.2998
– volume: 48
  start-page: 1279
  issue: 10
  year: 2016
  ident: pmed.1004451.ref031
  article-title: A reference panel of 64,976 haplotypes for genotype imputation
  publication-title: Nat Genet
  doi: 10.1038/ng.3643
SSID ssj0029090
Score 2.4722342
Snippet Osteoporosis is a major global health issue, weakening bones and increasing fracture risk. Dual-energy X-ray absorptiometry (DXA) is the standard for measuring...
Background Osteoporosis is a major global health issue, weakening bones and increasing fracture risk. Dual-energy X-ray absorptiometry (DXA) is the standard...
Yong Liu and co-workers compare
BackgroundOsteoporosis is a major global health issue, weakening bones and increasing fracture risk. Dual-energy X-ray absorptiometry (DXA) is the standard for...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e1004451
SubjectTerms Absorptiometry, Photon
Adult
Aged
Biological models
Biology and Life Sciences
Bone densitometry
Bone Density - genetics
Bones
Density
Ethnicity - genetics
Female
Femur Neck - diagnostic imaging
Genes
Genomics
Health aspects
Humans
Lumbar Vertebrae - diagnostic imaging
Male
Medical research
Medicine and Health Sciences
Medicine, Experimental
Middle Aged
Osteoporosis
Osteoporosis - diagnosis
Osteoporosis - genetics
Osteoporotic Fractures - genetics
Physical Sciences
Polymorphism, Single Nucleotide
Research and Analysis Methods
Risk Assessment - methods
Risk Factors
Single nucleotide polymorphisms
Social aspects
United Kingdom
White People - genetics
World health
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gLojxTChiE4JQ2iZ0Xty2lKkhbJKDV3iy_0l0JeaNm99C_wS9mxvGGjUBqD9yy8Rcr6xmPZ-KZz4S8zbQtKpOpWGJZD6-NimutS7gC55vzOjM-GXN6Vpye8y-zfLZ11BfmhPX0wP3AHcKKJTkEBRiKQAeVLCQ3FtxsUDRZFZ69NKmTTTAVQq068V9XkH8sTrOyDEVzrEwPg4wOWlhtDjxfWp6OFiXP3f-3hd5aosbpk1vr0ckDcj84knTS_4Fdcse6h-TuNGyVPyK_LiAK7km4r-nC0fZPhQBdNhT0BssXY-vmPgeAHs8m8dH0mLZX2AWKi_pTcjoq_UtT4zM4LLWruVtoKp2BTnrCa_jZDgeBdR_ohGLG-nZXnsX2MTk_-fTj42kcDmCINcSuq9iWZQXunm5AoNoyWTcc3B1VqCzJFYSzEPxkpmBWlbK2Siq4UzfKpPDWEnTDsidkxy2dfUZoUTGrTZ4z3hgOMbkEU9zUhUJ3DKlxI8I2EhA6sJPjIRk_hd9yKyFK6cdVoNxEkFtE4uGptmfnuAF_hMIdsMit7W-AxomgceImjYvIK1QN0ReqDhZCTJBXCO1nFZE3HoH8Gg4TeC7luuvE568XtwB9P7sN6NsI9D6AmiWMmZahsgJGHsm9Rsh3I-RlT23-L-D-CAg2R4-aX2-mhcAmTNRzdrnuBIOIo8LtdsA87afJMNrgiqeMcxaRajSBRuIYt7jF3FOep8gCVfF8738I8Dm5l4Fr6ncGkn2ys7pa2xfgWq7US29FfgP7t3XC
  priority: 102
  providerName: Directory of Open Access Journals
Title Variability in performance of genetic-enhanced DXA-BMD prediction models across diverse ethnic and geographic populations: A risk prediction study
URI https://www.ncbi.nlm.nih.gov/pubmed/39213443
https://www.proquest.com/docview/3099803048
https://pubmed.ncbi.nlm.nih.gov/PMC11404845
https://doaj.org/article/819a489921844918a6a4de487870a865
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1tb9MwELbGJiG-IN4XGMUgBJ9SNYnzhoRQyzYNUAsMOvWbZTtOW2lKStNK7G_wi7lz3NCIIfqlauMnVuqzz3fx3XOEvPSVjpLMl67AtB6WZtJNlYrhGxjfjKV-ZoIxh6PobMw-TsLJHtnUbLUDWF3r2mE9qfHysvvzx9U7WPBvTdWG2Nvc1F3A_tE1DGiYU31gTowwmI815wp-2jNvXZCXzPX8OLbJdP_qpbVZGU7_vzX31tbVDqvc2qdO75Db1sCk_XpG3CV7urhHbg7tEfp98usCvOOanPuKzgu6-JM5QMucwnzCtEZXFzMTG0CPJ313MDymiyV2gWKkpnpORYV5aJqZyA5N9WpWzBUVRQad1ETY8HPRFAir3tA-xUj27a4Mu-0DMj49-f7-zLWFGVwFPu3K1XGcgBmochC00oFIcwZmkIyk3wsluLngFPlZFGgZi1RLIeFKmsvMg6cWMGd08JDsF2WhDwmNkkCrLAwDlmcMfHUBKjpPI4lmGlLmOiTYSIAry1qOxTMuuTmKi8F7qceVo9y4lZtD3OauRc3a8R_8AIXbYJFz21wol1NulzAH20kwcE_RKYapnIhIsEyDwwcqTyRR6JBnODV4ncDaaA7eR74h1KuJQ14YBPJuFBjYMxXrquIfPl_sAPo22gV03gK9tqC8hDFTwmZcwMgj6VcL-aqFnNaU59cBj1pA0EWq1fx8syw4NmEAX6HLdcUD8EQSPIYHzKN6mTSjDSa6FzAWOCRpLaCWONotxXxmqNA9ZIdKWPh457_6hNzywS41xwK9I7K_Wq71U7ArV7JDbsSTuEMOBiejL-cd83YGPj99TTpGifwGoUh9bA
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Variability+in+performance+of+genetic-enhanced+DXA-BMD+prediction+models+across+diverse+ethnic+and+geographic+populations%3A+A+risk+prediction+study&rft.jtitle=PLoS+medicine&rft.au=Liu%2C+Yong&rft.au=Meng%2C+Xiang-He&rft.au=Wu%2C+Chong&rft.au=Su%2C+Kuan-Jui&rft.date=2024-08-30&rft.pub=Public+Library+of+Science&rft.issn=1549-1277&rft.volume=21&rft.issue=8&rft_id=info:doi/10.1371%2Fjournal.pmed.1004451&rft.externalDocID=A807403058
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1549-1676&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1549-1676&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1549-1676&client=summon